Different effects of amino acid‐based and glucose‐based dialysate from peritoneal dialysis patients on mesothelial cell ultrastructure and function

• Published in: Nephrology, dialysis, transplantation Vol. 18; no. 6; pp. 1086 - 1094
• Main Authors: Chan, Tak‐Mao, Leung, Jack Kok‐Hung, Sun, Yuling, Lai, Kar‐Neng, Tsang, Ryan Chi‐Wai, Yung, Susan
• Format: Journal Article
• Language: English
• Published: Oxford Oxford University Press 01.06.2003
• Subjects: Adult; amino acid; Amino Acids - pharmacology; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy; Biological and medical sciences; Cell Survival; Cells, Cultured; Dialysis Solutions - pharmacology; Emergency and intensive care: renal failure. Dialysis management; Female; glucose; Glucose - pharmacology; Humans; Intensive care medicine; Interleukin-6 - metabolism; interleukin‐6; Kidney Failure, Chronic - therapy; Male; Medical sciences; mesothelial cell; Middle Aged; Peritoneal Dialysis; Peritoneum - cytology; Peritoneum - drug effects; Human; Hemodialysis; amino acid; Dialysate; Dialysis fluid; Glucose; Dextrose; Peritoneal dialysis; interleukin-6; Peritoneal fluid; mesothelial cell; Extrarenal dialysis; Lactates; Deterioration; Nutritional status
• ISSN: 0931-0509; 1460-2385
• DOI: 10.1093/ndt/gfg096

Background. Peritoneal dialysis fluid (PDF) containing amino acids has been introduced recently aiming to improve the nutritional status of PD patients. Dextrose‐based PDFs have been implicated in progressive functional and structural deterioration of the peritoneal membrane. Limited data are currently available regarding the effect of amino acid‐based PDF on the function and ultrastructure of human peritoneal mesothelial cells (HPMCs), which play a critical role in peritoneal membrane pathophysiology. Methods. We investigated the effects of two commercially available PDFs, which utilized dextrose (1.5% Dianeal) or amino acids (1.1% Nutrineal) as the osmotic agent, obtained from patients after a 4 h dwell, on HPMC proliferation (MTT assay and cell counting) and viability [lactate dehydrogenase (LDH)release], interleukin‐6 (IL‐6) secretion (commercial enzyme‐linked immunosorbent assay) and ultrastructure (scanning and transmission electron microscopy). Results. Exposure of HPMCs to 1.5% Dianeal reduced cell proliferation, total cellular protein synthesis, IL‐6 secretion and cell attachment, but prolonged the cell doubling time on recovery, and increased LDH release (P<0.001, P<0.001, P<0.0001, P<0.0001, P<0.001 and P<0.001, respectively). The 1.1% Nutrineal reduced HPMC proliferation (P<0.001) and increased IL‐6 secretion (P<0.0001), but did not affect cell attachment, LDH release, protein synthesis or cell doubling time. Ultrastructural studies of HPMCs exposed to Dianeal showed cell flattening, increased cell surface area, reduced microvilli, and intracellular organelles compatible with dysfunctional mitochondria. In contrast, the ultrastructural morphology of HPMCs was relatively preserved after incubation with Nutrineal. Conclusions. Our results showed that HPMC ultrastructure, viability and protein synthesis were better preserved with amino acid‐based PDF, compared with conventional dextrose‐based PDF. The significance of IL‐6 induction by Nutrineal remains to be elucidated.